Medical Gases and Equipment Market Sparkling Key Players Shares, Revenue, Analysis and Forecasts to 2027

 Market Highlights:

The Global Medical Gases and Equipment Market held a market value of USD 13.0 billion in 2017 and is projected to grow at a CAGR of 7.5% over the forecast period. Medical gas is defined as the gas is manufactured, packaged, and used for administration to patients in diagnosis, anesthesia, and therapy. Medical gases are the life-saving element that provides direct influence in maintaining the life of patients. Medical gas equipment are the supply systems used by hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology industries to create or distribute medical gases in the piping system.

Few of the market growth factors are globally growing geriatric population coupled with increasing prevalence of chronic diseases, the presence of favourable government initiatives such as industry-friendly safety, and rising demand for point of care products & home healthcare. The Centers for Disease Control and Prevention (CDC) reported that, in the US, 6 in 10 adults have a chronic disease and 4 in 10 adults have two or more chronic diseases such as heart disease, cancer, chronic lung disease, stroke, diabetes, and chronic kidney disease (CKD)

Major Key Players

• Praxair Technology, Inc.
• Atlas Copco AB
• Air Liquide
• Airgas, Inc.
• Messer Group GmbH
• Matheson Tri-Gas, Inc.
• The Linde Group
• TAIYO NIPPON SANSO CORPORATION
• Amico Corporation
• SCI Analytical
• SOL S.p.A.
• Rotarex SA
• GCE Holding AB
• Air Products and Chemicals, Inc.
• Matheson Tri-Gas, Inc.
• Others

Segmentation:

The global Medical Gases And Equipment Market has been segmented into product, application, and end user.By product, the market has been segmented into medical gases, medical gas mixtures, and medical gas equipment. The medical gases segment has been further categorized into nitrogen gas, nitrous oxide gas, oxygen gas, carbon dioxide gas, helium gas, and medical air.

The medical gas mixtures segment is further categorized into medical laser gas mixtures, medical drug gas mixtures, sterilant gas mixtures, lung diffusion mixtures, blood gas mixtures, aerobic gas mixtures, anaerobic gas mixtures, and breathing zone monitoring calibration standard. The medical gas equipment is further categorized into air compressors, vacuum systems, flow meters, cylinders, alarm systems, masks, and others (manifolds, regulators, and outlets).

On the basis of application, the market has been segmented into therapeutic applications, diagnostic applications, pharmaceutical manufacturing & research, and others. The therapeutic applications segment is further categorized into respiratory therapies, cardiovascular therapies, anesthesia delivery, and others.Based on end user, the market has been segmented into hospitals & clinics, academic & research institutions, pharmaceutical & biotechnology companies, and home healthcare.

Regional Analysis:

The Global medical gases and equipment market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. On the basis of region, the Americas is likely to dominate the global medical gases and equipment market owing to the increasing adoption of advanced technologies and the presence of major market players & target population in the U.S. and Canada. Europe will hold the second largest market position over the forecast period due to flourishing growth in medical device industry and the presence of medical gas associations, viz. the MGA (Medical Gas Association) and EIGA (European Industrial Gases Association)

The Asia-Pacific is anticipated to witness comparatively higher CAGR during the forecast period owing to growing population in India and China, increasing awareness among patients, caregivers and healthcare professionals about medical gases, and developing healthcare infrastructure in the region. The Middle East & Africa has the least share of the global medical gases and equipment market. Additionally, the major market share of the region would be held by the Middle East region attributed to rising incidences of conventional diseases and increasing technological innovations in the UAE, Saudi Arabia and Qatar.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Electron Microscope Market Professional Survey Forecasts by 2027

 Electron Microscope Market Overview

In the Healthcare industry, technological advancement is resulting in the progress of advanced medical treatments and more accurate diagnostics of different kinds of ailments. The electron microscope offers higher magnification by using a beam of electrons to create an image of the specimen. Contrary to the light microscope, the greater resolving power of electron microscope allows it to see much smaller objects in finer detail. Market Research Future (MRFR) has published a research report regarding global electron microscopes market that estimates rise for this market with 7.9% CAGR (Compound Annual Growth Rate) for this market between 2022 and 2027. In terms of cash, the market that is worth the USD 3.4 bn in 2022 is expected to be worth the USD 5.36 bn in 2027.

Analyzing the market structure, this report offers insights about factors affecting the market growth. Evaluating market size and forecasting the revenue, this report covers and observes the competitive developments of market players that include joint ventures, mergers and acquisitions, new product developments, research, and developments (R & D), and strategic alliances. The key factors driving the growth of electron microscope market include increasing life science applications of the electron microscope and R & D expenditure across varied regions around the world, technological advancement, and high level of study regarding research.

Key Players

The key players in the global electron microscope market include Agilent Technologies, Angstrom Advanced Inc., Bruker Corporation, Carl Zeiss International, Hirox Ltd., Hitachi High-Technologies Corporation, JEOL Ltd., KEYENCE CORPORATION, Leica Microsystems, Merck KGaA, Nanoscience Instruments Inc., Nikon Metrology Inc., Olympus Corporation, Phenom-World, and Thermo Fisher Scientific.

Segmentations:

The Electron Microscope Market has been segmented on the basis of application, type, and region. Based on applications, this market has been segmented into life sciences, material sciences, nanotechnology, semiconductors, and others. By types, the market segmentation covers the reflection electron microscope (REM), scanning electron microscope (SEM), transmission electron microscope (TEM), and others.

Regional Analysis:

The regional segmentation of the global electron microscope market segments the market into continent-based regional markets known as The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas are the largest regional market. The factors driving the market growth in this region include the availability of advanced medical facilities and the presence of several key market players in North America. North America alone holds the potential to be the largest market due to its strong economies are known as the United States of America (USA) and Canada. Many key market players are based in the USA. In this region, the availability of advanced medical facilities makes North America a bigger market than South America.

Europe is another important regional market due to the high density of population and the availability of maximum advanced medical facilities after North America. Due to the reasons same as The Americas, Western Europe as a market is bigger than Eastern Europe. In this region, the key country-specific markets are France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Western Europe and then by Eastern Europe.

During the forecast period, Asia Pacific has the potential to emerge as the fastest growing market growing demand for improved medical facilities in this region. The weighty country-specific markets in this region are Australia, China, India, South Korea, and Japan, followed by the rest of the Asia Pacific region.

The MEA region shows limited market slow and steady growth. The reasons for the slow market growth in this region are lack of awareness, lack of education, lack of technological development, political instability, poor access to treatment, poor healthcare facilities, and healthcare not considered a priority by most governments.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Ultrasound Probe Disinfection Market by Forecast Revenue, Trends, Share, Demand by 2027

 Market Highlights

The Ultrasound Probe Disinfection Market is expected to witness tremendous growth owing to the rising demand for disinfectant probes in hospitals, increasing cases of bacterial infection in healthcare center during the treatment, and increasing implementation of high-level disinfection process for critical ultrasound probes. The global ultrasound probe disinfection market was estimated USD 314.1 million in 2022 and expected to reach USD 819.1 million by 2027 at a healthy CAGR of 21.1% by 2027.

However, factors such as high cost of switching, maintenance cost for the ultrasonic instrument may hinder the market growth during the forecast period.

Key Players

Some of the key players in the global ultrasound probe disinfection market are STERIS (UK), Nanosonics (Australia), Tristel (UK), Ecolab (US), Schülke & Mayr (Germany), Advanced Sterilization Products (US), CIVCO Medical Solutions (US), Germitec (France), Parker Laboratories (US), CS Medical (US), Virox Technologies (Canada), and Metrex Research (US).

Segmentation

The Global Ultrasound Probe Disinfection Market is segmented on the basis of product, probe type, by process and end-user. The ultrasound probe disinfection market, by product, is segmented into instrument, service, and consumables. The instrument is segmented into automated probe reprocessors, UV-C disinfectors, manual reprocessors/soaking stations, and ultrasound transducer storage cabinets. The consumables are sub-segmented into formulation, type of disinfectants, and detergents. The disinfectants, by formulation, is segmented into disinfectant wipes, disinfectant liquids, and disinfectant sprays. By type, consumables are segmented into high-level disinfectants, and intermediate/low-level disinfectants and detergents are segmented into enzymatic detergents and non-enzymatic detergents.

By probe type the market is segmented into linear transducers, convex transducers, phased array transducers, end cavitary transducers, transoesophageal echocardiography transducers| (TEE), and other. On the basis of process, the market is segmented into high-level disinfection and intermediate/low-level disinfection. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centres, ambulatory care centers, academic & research institutes, and others.

Regional Analysis

The Americas leads in the ultrasound probe disinfection systems market owing to the increasing prevalence of rising incidence of bacterial infection, increasing research & development in ultrasound probe disinfection and growing healthcare expenditure. According to the Consumer Report Organization and Centers for Disease Control and Prevention (CDC)  July 2015 publication, it is estimated that every year approximately 648,000 patients in the US got infected by bacteria during a hospital stay, and around 75,000 died. The increasing incidences of bacterial infection may support this market positively.

Europe is the second largest ultrasound probe disinfection market during the forecast period due to increasing prevalence of human papillomavirus (HPV). The human papillomavirus is a skin to skin transmitted disease. According to the Oxford Vaccine group fact sheet, HPV infection causes cervical cancers. It was also reported that 99% of cervical cancers are caused by the Human Papillomavirus (HPV) infection. Furthermore, it was also maintained that 3,126 new cases of cervical cancer were reported in the UK in 2015. The increasing prevalence of HPV infection supports the market growth in this region.

Asia-Pacific was estimated to be the fastest growing region for the global ultrasound probe disinfection market in 2017. The market is expected to witness high growth owing to the rising prevalence of bacterial infections. The Middle East and Africa holds the low share for this market. However, the rising healthcare awareness at the hospital and in the community are expected to influence the market positively.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Sterilization Equipment Market Therapeutics Review Analysis 2027

 Sterilization Equipment Market -Overview

The surge in the COVID pandemic is estimated to promote the sterilization equipment market. The market's report is efficiently analyzed as per MRFR, which provides outlooks for the global markets. By 2023, the market is estimated to gain a 7.0% CAGR in the near future.

The investment in sterilization equipment is estimated to rise sharply due to the increased infection rate of contagious diseases like SARS-CoV-2. The development of cutting-edge and effective equipment due to robust research and development strategies is estimated to promote the sterilization equipment market in the near future. The collective cases of hospital-acquired infections are anticipated to motivate the development of the sterilization equipment market companies in the forecast period.

Competitive Analysis

The market is projected to witness a period of turbulence with the impact of the pandemic on the workforce and the economy as a whole. The collaborative efforts of the market contenders are expected to broaden the horizons for development in the foreseeable future. The measures being undertaken to ensure seamless functioning of the market is estimated to lay off in the long run. The contenders in the market are likely to see aggressive competition in the coming years. The reimagined market structure is predicted to rely on a combination of robust online selling capabilities and a capable supply chain. The investment towards cutting-edge technology is anticipated to take a sharp surge with amplified funding accessibility. The formation of strong trade relations among several regions is forecasted to have a beneficial effect on growth. The focus on the client's needs is estimated to be more important than before as changes in living standards can have a notable bearing on the popularity of certain market trends.

The notable companies in the sterilization equipment market are Midmark Corporation, Advanced Sterilization Products (Division of Ethicon), Belimed, Boekel Scientific, Celitron Medical, Technologies Kft., Fedegari Autoclavi S.p.A., Cantel Medical., LTE Scientific, Merck & Co., Inc, 3M, Anderson Products, STERIS plc., Getinge AB, Sotera Health, and MMM Group.

Segmental Analysis

The segmental overview of the sterilization equipment market is carried out on the basis of product, end user, and region. The product segment of the sterilization equipment market consists of low-temperature sterilization, ionizing radiation sterilization, filtration sterilization, and heat sterilization. The region segment of the sterilization equipment market consists of Europe, the Middle East, Asia Pacific, the Americas, and Africa. The end-user segment of the sterilization equipment market consists of research institutes, pharmaceutical companies, medical device companies, food & beverage industry, and hospitals & clinics.

Regional Overview

The regional examination of the sterilization equipment market consists of Europe, the Middle East, Asia Pacific, the Americas, and Africa. The Americas sterilization equipment market is estimated to overshadow the global market owing to the gradually severe sterility guidelines, upsurge in the number of surgical practices due to rising elderly residents, the incidence of a fixed healthcare system and implementation of highly advanced technology. The European sterilization equipment market is anticipated to be the second principal market. The market augmentation in this region can be accredited to the expanding government spending on healthcare and collective research pursuits in the life sciences sector. The Asia Pacific sterilization equipment market is expected to be the fastest mounting market in the forecast period due to the growing prevalence of long-lasting diseases, a growing number of hospitals and research organizations in the APAC region and development in the healthcare and biotech business.

Industry Updates:

May 2021 NextBeam, a medical equipment sterilization company, is building a USD 20 million facility on the previous Gateway campus. NextBeam will also inhabit some space in buildings near the facility, which was among the former black-and-white cow-spotted metal buildings the computer maker constructed in the 1990s.   The company's move comes after being approved for a USD 3 million in REDI or Revolving Economic and Development Initiative loan by the South Dakota Board of Economic Development past year.

Nov 2020 A novel portable solar-powered device that competently harnesses the sun's energy to make steam at elevated temperatures and pressures even in misty or cloudy circumstances has been developed recently. A group of engineers from MIT and the Indian Institute of Technology Bombay have made a simple solar-powered system that warms up water to create steam fed to an autoclave cavity.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Minimally Invasive Cosmetic Procedures Market Forecast Indicators Trending Lucrative Growth Till 2027

 According to the MRFR reports, the global minimally invasive cosmetic procedures market is projected to attain a valuation of USD 8,400.33 million by 2027 while registering a healthy CAGR of over 8.68% during the review timeframe.

Minimally invasive surgeries refer to making small incisions on the body. The global market for these procedures has been witnessing massive growth over the years owing to the factors such as effective marketing strategies by key players, rising healthcare expenditures, the growing medical tourism industry, increasing demand for minimally invasive cosmetic surgery, and a rising number of product launches and approvals. However, the market growth is anticipated to be hampered by the complications related to cosmetic procedures and unfavorable reimbursement scenarios.

Segment Analysis

The global minimally invasive cosmetic procedures market is divided into several segments based on products, procedures, application, end-user, and region.

Based on product, the global market is divided into microdermabrasion products, botulinum toxins, hair removal lasers, and others.

Based on procedures, the minimally invasive cosmetic procedures market is split into microdermabrasion, laser hair removal, chemical peel, soft tissue fillers, botulinum toxins, and others.

The minimally invasive cosmetic procedures market is divided into applications such as adipose tissue regeneration, hyperpigmentation, trauma scars, acne, etc.

The global market is bifurcated into dermatology clinics, hospitals, and others based on end-users.

Competitive Analysis

The global Minimally Invasive Cosmetic Procedures Market offers both existing and new players lucrative. The market has an intensely competitive landscape with many players spread worldwide. The players worldwide adopt the latest strategies such as product development, research, partnerships, mergers, and several others to strengthen their market position. The list of prominent players across the global market includes Cutera, Inc. (U.S.), New Shining Image L.L.C. (U.S.), Advanced Microderm Inc. (U.S.), Altair Instruments (U.S.), The Procter & Gamble Company (U.S.), Lasertec Medical Services (Ireland), Dermaglow (U.S.), Silhouet-Tone Corporation (Canada), Koninklijke Philips N.V. (Netherlands), AbbVie Inc. (U.S.), and several others.

Recent Developments

• December 2021 – a medical device company specializing in highly effective, cost-effective, minimally-invasive, and non-invasive treatments for oncological and non-oncological conditions, Sensus Healthcare, Inc. announced an exclusive distribution agreement for the U.S. region with Mattioli Eng. Italia S.P.A. for Sensus's TransDermal Infusion System non-invasive drug delivery system.  The company strategizes to start marketing this System to dermatologists across the country starting right away.
• June 2021- P&G has announced the latest sensitive skin care brand launch, suitably named GoodSkin MD. The brand soft-launched on the company's D2C site and has now debuted on CVS.com to boot and is ready to hit the market in July. The brand is developed to be gender-inclusive and aimed at the millennial market. The product range includes six cleansers, rescue cream, a night cream, serums, and sunscreen.

Regional Analysis

The Minimally Invasive Cosmetic Surgery market is studied across four major regions, including Asia-Pacific, Europe, North America, and the Rest of the World.

The North American regional market has dominated the field globally in 2020 with a contribution of over 34% and is projected to exhibit a CAGR of over 9.18% during the review timeframe. The market's growth is attributed to a high number of cosmetic surgeons and the high popularity of cosmetic procedures.

The European region is anticipated to grow significantly over the review timeframe and display a CAGR of 7.90%. The regional market's growth is given the presence of key companies in the region, growing popularity of minimally invasive cosmetic procedures, and higher number of patients.

The Asia-Pacific region is likely to be the highest growing region globally over the coming years. The region's growth is attributed to factors such as the high percentage of the old-age population, growing demand for aesthetic procedures, and growing cosmetic expenditures.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Blood Glucose Monitoring Market Share Analysis, Strategies, Revenue and Forecasts to 2027

 Blood Glucose Monitoring Market Overview:

A healthy body stays healthy due to all kinds of enzymes in the body being in proper balance. Excess of an enzyme can disturb balance while deficiency of another one can have the same effect. People who are suffering from genetic ailments like diabetes are more prone to such problems. Therefore, monitoring things like glucose in the blood is necessary for such people, and this is the reason for the global blood glucose monitoring market to take shape and grow. Blood glucose monitoring helps to recognize the glucose level of blood within the specified target range. The devices facilitating this monitoring provide useful insight to manage diabetes. These insights help to track the progress of treatment goal and observe the effect of medication on blood sugar level and understand how the ailment affects glucose level in blood.

Market Research Future (MRFR) has published a research report about the global blood glucose monitoring market that predicts the market growth with 7.1 % CAGR (Compound Annual Growth Rate) between 2017 and 2023. Devices known as blood glucose meter are designed to apply to the different type of diabetes. According to this report, the market for these devices is growing due to developing technology for monitoring and diagnosis of diabetes, early detection of diabetes, increasing demand for continuous glucose monitoring devices, and increasing prevalence of diabetes.

Key Players

The key players in the global blood glucose monitoring market include Abbott Laboratories (USA), Arkay, Inc. (the USA), Bayer Healthcare AG (Germany), Dexcom, Inc. (the USA), GlySure Ltd (UK), Goldsite Diagnostics Inc. (China), F. Hoffmann-La Roche Ltd (Switzerland), LifeScan, Inc. (the USA), and Sphere Medical Holding PLC (UK).

Segmentations:

In this report, the global Blood Glucose Monitoring Market has been segmented on the basis of application, end user, product type, and lastly, region. On the basis of application, this market has been segmented into type 1 diabetes, type 2 diabetes, gestational diabetes, and others. The first two types of diabetes harm the body in the same way. The difference between the first two types of diabetes is regarding insulin. Patients suffering from type 1 diabetes do not produce insulin. On the other hand, patients with type 2 diabetes do not respond to insulin as well as they should and later in the disease often do not make enough insulin. Their body produces a little bit of insulin but fails to use it effectively. Gestational diabetes only happens during pregnancy. The patient gets high blood sugar levels during pregnancy, despite their levels being normal before pregnancy.

On the basis of product type, the market has been segmented into continuous glucose monitoring (CGM), invasive glucose monitoring (IGM), and flash glucose monitoring. CGM is defined as an advanced way for people living with diabetes to check glucose readings in real-time or monitor them over a period of time. IGM refers to the measurement of blood glucose levels (required by people with diabetes to prevent both acute and chronic complications from the disease) by taking their blood sample. Flash Glucose Monitoring is a small sensor that diabetes patient wears on the skin. This sensor stores the user's blood glucose (or blood sugar) levels continuously. The user can access them by scanning the sensor at his/her ease. Based on end users, the market has been segmented into clinics, diagnostic centers, home care diagnostics, hospitals, and research centers.

Regional Analysis:

The regional segmentation of global Blood Glucose Monitoring Market Growth segments the market into regions namely The Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA). The Americas command the largest market share due to the notable increasing incidence of obesity, physical inactivity, and unhealthy diet. With medical facilities being more advanced in North America, it is a bigger market than South America. In North America, the biggest markets comprise of the United States of America (USA) and Canada. Many key players in this market are based in the USA.

Due to reasons same as The Americas, in Europe, Western Europe is greater market than Eastern Europe. Europe is the second largest market for blood glucose monitoring, followed by the Asia Pacific in the global blood glucose monitoring market, owing to the environmental pollutants, psychosocial factors, smoking, and socioeconomic deprivation. Furthermore, government support via for research & development (R & D) regarding blood glucose monitoring boosts this market. The biggest markets in Europe, include France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Europe.

In the Asia Pacific region, the market is growing rapidly due to high population and increasing number of diabetes patients. In this region, people are not as health conscious as they are in North America and Europe. Due to increasing demand for new treatment methods in countries like India and South Korea, Asia Pacific is likely to emerge as the fastest growing market across the globe during the forecast period. Apart from India and South Korea, the biggest markets in this region include Australia and Japan, followed by the rest of Asia Pacific.

In the MEA region, the market is small and limited due to little investment in healthcare and lack of awareness about health problems. In this region, the biggest market comprises of Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates (UAE), followed by rest of MEA region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Halitosis Treatment Market | Projected to Grow Radiantly by Top Players Revenue and Growth Rate by 2027

 Halitosis Treatment Market: Segmental Analysis

The global halitosis treatment market has been segmented on the basis of indication, type, drug treatment, and diagnostic test.

By mode of type, the global halitosis treatment market has been segmented into pathological halitosis and others.

By mode of indication, the global halitosis treatment market has been segmented into liver, respiratory, gastrointestinal, kidney, systemic, and others.

By mode of diagnostic test, the global Chronic Halitosis Treatment market has been segmented into gas chromatography, halimeter, β-galactosidase activity assay, BANA test, and other tests.

By mode of drug treatment, the global halitosis treatment market has been segmented into antiseptic, antacids, ranitidine and other drugs.

Halitosis Treatment Market - Market Scenario

The global halitosis treatment market is predicted to register 18.58% CAGR during the forecast period (2022-2027). The market is anticipated to garner USD 22,153.4 billion owing to the increasing incidences of periodontal diseases, asserts Market Research Future (MRFR). Halitosis is referred to as a clinical condition which is characterized by an unpleasant odor of the mouth owing to several chronic and periodontal diseases. Halitosis has become one of the major social problems which have affected a large number of the population globally.

Halitosis Treatment Market - Competitive Dashboard

The noteworthy players operating the global halitosis treatment market are Listerine (U.S), Colgate-Palmolive Company (U.S), All USA Partners LLC (U.S), Dr. Harold Katz LLC (U.S), Rowpar Pharmaceuticals Inc. (U.S), Abbott (U.S), and AstraZeneca (U.S).

Drivers and Constraints Impacting the Market

Halitosis is mainly caused due to lack of awareness regarding the diagnosis of the particular disease and also lack of oral hygiene. The global halitosis treatment market is forecasted to demonstrate a stellar growth rate owing to the accelerating geriatric population, availability of a varied range of dental care products in the market and increasing incidences of periodontal diseases across the world. The market is getting enough tailwinds from quarters such as advancements in healthcare technologies. Also, initiatives by the government along with technological support are some of the other major factors highly contributing to the market growth. Moreover, surgical, endodontic, and pathological factors like a non-vital tooth with fistula which drains into the mouth and exposed tooth pulps, oral cavity pathologies, oral cancer, healing wounds, extractions or prosthetics, and ulcerations are some of the prominent factors influencing the market growth to a great extent. Such factors lead to plaque or food retention area, increasing amount of bacteria, the decay of amino acids, the decrease in saliva flow, and tissue breakdown. Additionally, manufacturers are focused on the approval and development of new products besides collaborations with other industry players, thereby propelling the market growth.

On the flip side, lack of awareness among the global population regarding the diagnosis and treatment of halitosis is predicted to slow down the market growth to a large extent.

Industry Updates

September 11, 2022: The Arizona Bioindustry Association has honored the AZBio Fast Lane Award to Rowpar Pharmaceuticals, Inc., at the 2022 AZBio Awards for developing products for people to maintain oral hygiene. The organization is dedicated to offering CloSYS oral health products, which contains Cloralstan. The ingredient attacks microorganisms and destroys pathogens associated with gum diseases and maintains oral hygiene.

Halitosis Treatment Market - Regional Insights

Geographically, the Halitosis Treatment Market span across regions namely, Europe, America, Asia Pacific, and the Middle East & Africa.

Among all the regions, the American region is considered to occupy a significant share and is estimated to maintain its dominance in the coming years. The growth is credited to the extensive use of oral care products like mouthwashes, toothpaste, mouth sprays, etc. Also, with the increasing prevalence of gum diseases, the market in this region is presumed to flourish.

The European region is anticipated to occupy the second largest position globally owing to the rising awareness associated with halitosis and its available products available for treatment. Additionally, the augmenting demand for oral care products further influences the market growth in this region.

The Asia Pacific is predicted to expand at a rapid pace owing to the augmenting prevalence of chronic diseases like respiratory diseases, diabetes, liver or kidney failure. Furthermore, with the growing geriatric population suffering from such chronic diseases also influences the market growth to a great extent in this region.

Meanwhile, the Middle East & Africa is presumed to experience a moderate growth rate during the assessment period owing to the poor economic conditions coupled with the lack of awareness regarding oral health.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Muscle Stimulator Market Share Analysis, Strategies, Revenue and Forecasts to 2027

 Market Highlights

The muscle stimulators use electric current to elicit contraction in muscles or nerves. The electric signal has intensity and frequency which mimics the nerve signal system.

The muscle stimulator market is also witnessing high technological development. The manufacturing of medical devices in general and muscle stimulators in particular is also undergoing changes. The latest technological advancements include active research in frequencies and strength of electric current used for muscle stimulation. Increasing miniaturization and portability of the muscle stimulator devices is another development that is driving the growth of the market.

Market fragmentation and falling profit margin are significant threats to the market. The rise of low cost manufacturing economies such as China are challenging the high-tech segment. The muscle stimulators market credibility is being challenged by the rise of spurious low-quality products. There has been cases of burns and skin irritation due to improper use of these low-quality muscle stimulators.

The muscle stimulator market is also becoming more customer oriented and there is increasing demand for personalization and customization which has created the demand for smart muscle stimulators. The muscle stimulators today are a far cry from what they use to be. The latest hi-tech muscle stimulators use the advanced software’s which can set the device into a predefined cycle with suitable shifts. The latest muscle stimulators have started getting synchronized with mobiles. Mobile apps will eventually contain all the data in one single point. Connected healthcare muscle stimulators seems to be the future due to their cost reducing effect and the ability to converge data at a single point for analysis.

Global Muscle stimulator Market Players:

Key players profiled in the report are DJO Global, Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix, Inc., OMRON Corporation, Tone-A-Matic.

Segmentation:

The global Muscle Stimulator Market is segmented on the basis of products. Based on the products, the market has been segmented as transcutaneous electrical nerve stimulator, burst mode alternating current, neuromuscular electric stimulation, and interferential current. Based on the application, the market has been segmented as pain management, neurological and movement disorder management and musculoskeletal disorder management.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Middle East and Africa Critical Care Equipment Market Forecast Indicators Trending Lucrative Growth Till 2027

 Market Highlights

The Middle East and Africa critical care equipment (CCE) market has been evaluated to be growing moderately and is expected that it will continue to grow at the same pace in future as well. This market was US$ 681.2 million in 2016 and is expected to reach US$ 1061.4 million by 2023 growing at the CAGR of 5.7%. Critical care is very important medical procedure planned to cure critical medical conditions such as severe illness, injuries or both. Hospitals have their own critical care unit (CCU) or commonly known as intensive care unit (ICU) to monitor, diagnose and treat patients under controlled medical conditions with the help of critical care equipment. These are technologically advanced devices which monitors and collects accurate data about patients’ current medical condition. CCE also provides life support to patients so that patients can maintain organ functioning in life threatening medical conditions including severe injuries, illness or both.

Middle East and Africa is one of the prominent and growing market for the healthcare sector. Due to increase in per capita income, the expenditure on healthcare is also increasing in this region. Non-communicable diseases like stroke and heart diseases are rising rapidly and are major market driver for critical care equipment in these regions. The critical care equipment market in these regions is expected to grow at the CAGR of 10% annually and which boosts growth of the overall healthcare industry. Hospitals in these regions are spending about 20%-30% of their budget on critical care units. Medical equipment manufacturers are spending money on R&D to develop more advance and innovative products for the CCE market. Continuous innovation and growing adoption of new technology are leading the growth of this market.

Test the market data and market information presented through more than 40 market data tables and figures spread over 65 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Middle-East and Africa critical care equipment (CCE) Market Research Report –Forecast till 2022.”

Middle-East and Africa Critical Care Equipment (CCE) Market Players:

There are plenty of large and small market players which operates in this Middle East and Africa Critical Care Equipment Market all over Middle East and Africa region, namely Johnson & Johnson Services, Inc. (US), General Electric Company (US), Medtronic (Republic of Ireland), Siemens Healthcare Private Limited (Germany), Baxter (US) and Koninklijke Philips N.V. (Netherlands)

Considering the scenario of Middle East and Africa market, UAE region is believed to be the largest market for critical care equipment in these regions. Moreover, Saudi Arabia market is also growing and is the second largest market for CCE.  On the other hand, Egypt’s market is expected to grow at a steady pace in Middle-East critical care equipment market during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in this market.

Segmentation:

Middle East and Africa Critical Care Equipment Market has been segmented on the basis of type of Critical Care Equipment which includes patient monitor, medical ventilator, dialysis, IV pumps, infusion pump, suction apparatus and others. On the basis of end user of the market, the same has been is segmented into hospitals, research laboratories and others.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Transplant Diagnostics Market Share Analysis, Strategies, Revenue and Forecasts to 2027

 Transplant Diagnostics Market Overview:

Market Research Future (MRFR)’s latest research reveals that the global transplant diagnostics market is set to surpass the value of USD 2,074.65 million by 2027. The global market is anticipated to grow at CAGR of 7.80% during the forecast period (2022–2027). The global transplant diagnostics market is anticipated to flourish in the coming years with the growing prevalence of chronic diseases that can lead to organ failure. The market has triggered the curiosity of healthcare providers on account of various benefits offered by these tests to assess the feasibility of the organ transplant procedure. Also, there has been a barrage of research and development activities that lead to technological advancements in the transplant diagnostics field. MRFR notes that the market is in a mature phase in developed economies such as North America while developing countries hold immense potential and show promise in the coming years. Another factor proving to be beneficial for the market is increasing geriatric population who are in constant need of organ transplant. To sum it up, rise in technological advancements, increased research and development activities and growing number of transplant procedures have shaped the market size significantly.

However, marring the transplant diagnostics market are few restraints including high cost of the transplant procedure. Nonetheless, the market growth is inevitable due to government initiatives across the globe to promote organ transplantation along with continuous technological innovations undertaken by global market players.

Global Market for Transplant Diagnostics – Competitive Dashboard

The key players in the global transplant diagnostic market are Becton Dickinson and Company, F. Hoffmann La Roche Ltd., Bio-Rad Laboratories Inc., QIAGEN N.V., Illumina, Inc., bioMérieux S.A., and Thermo Fisher Scientific Inc. and others.

Global Market for Transplant Diagnostics– Segmental Analysis

MRFR’s report states that the global Transplant Diagnostics Market is segmented based on product and service, screening type, organ type, application, and end-users.

By product and service, the market has been segmented on the basis of instruments, reagents & consumables, and software and services. The reagents & consumables segment presently holds the largest market share and is estimated to dominate the market throughout the assessment period.

By screening type, the market has been segmented on the basis of pre-transplant screening and post-transplant screening. The pre-transplant screening segment valued more than USD 819.04 million in 2022.

By organ type, the market has been segmented on the basis of kidney, liver, heart, lung, pancreas, and others. The kidney segment valued more than USD 896.02 million in 2022. Factors attributing to the growth of this segment include increasing cases of organ rejection combined with the side effects of medication.

By application type, the market has been segmented based on research applications, diagnostic applications, and others. Research Applications accounted for the largest share in the transplant diagnostics market in 2022 and is exhibited to retain its position in the market. The diagnostics procedure before and after transplant for research application is rising gradually. Moreover, the cost of diagnostic testing and procedure are known for their affordable prices.

By end-user, the market has been segmented on the basis of commercial service providers, hospitals and transplant centers, research laboratories & academic institutes and others. The hospitals and transplant centers was valued more than USD 544.77 million in 2022 and will retain its top position even till the end of 2027. The hospitals are credited as prominent diagnostic and treatment centers for transplant diagnostics, along with a variety of surgical procedures as well as diagnosis of these conditions are carried out in these facilities.

Regional Outlook

By region, the global market is segmented on the basis of Americas, Europe, Asia-Pacific (APAC), and the Middle East & Africa (MEA).

At present, Americas claims the largest market share and is bound to continue doing so in the coming years. The market growth in the region is due to well established healthcare industry and popularity of treatment methods in both the United States (U.S) and many Latin American countries. Furthermore, the diagnostic medical device industry is thriving and touted to be one of the largest sectors in the US.

Asia Pacific is bound to remain an important market in the global market during the assessment period. Growing demand for organs such as kidney and liver is presumed to trigger the growth of the market in the region. Furthermore, accelerating cases of organ diseases such as liver cirrhosis, acute renal failure has led to governments focusing on funding research to develop organs. This factor proves to be highly crucial in the market growth in the region in the coming years. Also, the region has a high geriatric population who are prone to chronic diseases and are in dire need of organ transplants.

The Europe market has managed to create a niche for itself on account of growth in robot-assisted laboratory automation of diagnostic procedures coupled with technological advancement in the field of human leukocyte antigen (HLA) typing. In addition, increasing public-private investment to develop innovative human leukocyte antigen (HLA) testing products has also resulted in market expansion to a large level.

Lastly, the Middle East and Africa markets are aggressively making their way into the global market. This market expansion in the region is due to improving healthcare infrastructure and continuous reduction in average cost of gene sequencing. It has also been observed that global market players are striving to penetrate the regional market and widen their customer base locally. This intense competition and ambition displayed by such firms fuel the market growth in the region and is expected to surmount in the coming years.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cleanroom Consumables Market Therapeutics Review Analysis 2027

 Market Overview

The Cleanroom Consumables Market size would be valued at USD 3,384.49 million by 2027, estimates Market Research Future (MRFR). The global market will be soaring at a rate of 5.66% between 2021 and 2027, adds the new extensive study by MRFR.

Primary Boosters and Challenges

Cleanroom consumables enjoy a huge demand in the biotechnology and pharmaceutical industry for improved and better quality of the pharmaceutical drugs. Their use is also fostered by the encouragement from strict safety regulations by several regulatory entities such as Occupational Safety and Health Administration (OSHA), Food & Drug Administration (FDA), and World Health Organization (WHO), to maintain the product quality. These factors are touted to have a significant impact on the worldwide market in the next few years.

Soaring health concerns across the globe combined with the surge in infectious disorders, like the novel coronavirus, has raised the adoption of cleanroom consumables across numerous healthcare segments. Having said that, the complex nature of the stringent regulatory norms along with the environmental biohazards related to disposable cleanroom consumables can be a key challenge for the players in the future.

The COVID-19 pandemic negatively affected the workflows throughout the healthcare industry worldwide. The virus has forced several industries to shut down their businesses temporarily, including a number of sub-segments of healthcare. But, with the surging burden of the infectious disease, various healthcare services are now enjoying a massive demand, with one of them being cleanroom consumables, including coveralls, gloves, face masks, shoe covers, and others. These products are increasingly being used to facilitate a contamination-free and hygienic environment while collecting and testing samples of the suspected cases. Additionally, the resultant rise in exhaustive research and development activities to produce vaccines against the virus compels biopharmaceutical and pharmaceutical companies to spend considerably on the cleanroom consumable market.

Eminent Firms

Ansell Ltd. (Australia), Contec Inc. (US), DuPont (US), Berkshire Corporation (US), Valutek, Inc. (US), Cantel Medical (US), Texwipe (US), Kimberly-Clark Corporation (US), KM Corp (Korea), Micronclean (UK), are the major cleanroom consumables products and services providers in the global market.

Market Segmentation

Product along with application are the top segments considered in the MRFR study, to present a detailed framework of the cleanroom consumables industry.

Key products covered include Cleanroom Apparels, Cleanroom Products, Wipers, Cleanroom Stationery, Adhesive Mats, and Gloves.

Major applications are Medical Device Companies, Biotechnology Companies, Research Labs and Universities, Hospitals & Clinics, Pharmaceutical Companies, and others. Research labs and universities will be the leading end-users of cleanroom consumables in the next couple of years, thanks to the rising R&D funds worldwide.

Regional Status 

North America is prevailing as the global leader, on account of the presence of a thriving healthcare system, and the surge in medical screening activities. The steadily rising number of biopharmaceutical and pharmaceutical vendors in the region, vast presence of reputed players in the United States along with Canada coupled with their focus on merger & acquisitions as well as new launches also enhance the market size.

Get Full Report at https://www.marketresearchfuture.com/reports/cleanroom-consumables-market-10611

Asia Pacific will soon be achieving the fastest CAGR, with the soaring need for sterilized pharmaceutical formulations combined with the rise in technical advances in medical equipment. Innovations in synthetic clothing blends, mounting use of the electrostatic technology, and anti-microbial finishes will present growth opportunities as well. South Korea will remain one of the most profitable markets in the region, considering the flourishing semiconductor sector and the exploding number of memory chip developers. Meanwhile, the Indonesian industry will cover significant grounds too, on account of the constantly advancing healthcare sector in conjunction with the mushrooming middle-class population and their rising spending capacity.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Microcatheters Market | Projected to Grow Radiantly by Top Players Revenue and Growth Rate by 2027

 Market Highlights

According to MRFR analysis, the global microcatheters market is expected to register a CAGR of~4.1% from 2021 to 2027and hold a value of ~USD 2,412.0 million in 2027.

The global microcatheters market is driven by several factors, such as a rise in the prevalence of chronic diseases such as neurovascular, cardiovascular, and urology disorders, increased adoption of minimally invasive procedures, and development of new diagnostic centers and hospitals in developing regions. According to WHO, 17.9 million people die each year due to cardiovascular diseases, an estimated 31% of all deaths worldwide. The inclination toward minimally invasive surgeries is increasing due to its less risk than traditional surgeries because it uses smaller surgical incisions. Thus, the above-mentioned factors collectively are fueling the microcatheter market growth.

The industry players are launching new microcatheters with advanced technologies in the market. The companies are making high investments in R&D to launch unique products in the market. They are also making partnerships and acquisitions in the regions for future expansion. For instance, in March 2021, Boston Scientific (US) announced that it entered a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the global surgical business of Lumenis Ltd (Israel), a privately-held company that develops and commercializes energy-based medical solutions.

Key Players

Some of the key players in the global microcatheters market are Medtronic (US), Boston Scientific (US), Terumo Medical Corporation (US), Teleflex Inc. (US), Merit Medical Systems, Inc. (US), Guerbet (France), Cook Medical (US),Acandis GmbH (Germany), Acrostak (Switzerland), Stryker Corporation (US), Asahi Intecc (Japan), Lepu Medical Technology Company (China), and Cerus Endovascular Ltd (US).

Segmentation

The global Microcatheters Market has been segmented into design, product, application, and end use.

By design, the market has been segregated into single lumen and double lumen. The double lumen segment is expected to hold a considerable share of the market in 2020. The double lumen has various advantages, such as easy access to the procedural site. Increasing preference for interventional cardiology procedures of dual lumen microcatheter will augment the market growth in the assessed time period.

Based on application type, the global microcatheters market has been classified as cardiovascular, neurovascular, peripheral vascular, oncology, and urology. The cardiology segment held the largest segment share in 2020, owing to the rise in the prevalence of chronic diseases such as cardiovascular disorders across the globe.

Based on end user, the microcatheters market is classified into hospitals, specialized clinics, and ambulatory surgical centers. The hospitals segment held the largest market share in 2020 due tothe rise in the prevalence of target diseases and many surgical and diagnostic procedures performed across these facilities.

Regional Analysis

North America is expected to dominate the microcatheters market throughout the study period, owing to the growing geriatric population, increasing number of percutaneous coronary intervention procedures, availability and accessibility to technologically advanced products, and increasing government initiatives. According to the US Census Bureau, the US constitutes 34% of the population aged 65 or older, which has increased by 3.2% over a year. Among the different regions in North America, Maine ranks first with the highest geriatric population.An increased aging population leads to a rise in the number of people suffering from chronic diseases,which results ina high number of surgeries performed. This is increasing the demand for microcatheters across the region. Increasing investments in the development of advanced microcatheter to reduce complications during the surgical procedure have surged the level of competition amongst the market players. Moreover, the competitors are launching devices integrated with advanced technologies.

Eure holds the second-largest position in the microcatheters market due to the high demand for technologically advanced products and increased adoption of minimally invasive surgery across the region. In addition, countries such as Italy, Germany, France, Spain, and the UK have a large geriatric population, which is expected to support market growth.

Asia-Pacific is anticipated to be the fastest-growing regional market over the forecast period due to the presence of a large patient pool, increasing prevalence & incidence of target diseases, and growing healthcare infrastructure in Asian Countries. Moreover, other factors supporting the microcatheter market include increasing healthcare spending and government initiatives for strengthening the healthcare infrastructure.

The growth of the market in the Rest of the World is attributed to the technological advancements in microcatheters coupled with the expansion of distribution channels throughout the region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Needle-Free Diabetes Care Market 2027 Forecasts by Global Industry Analysis in 2022 Report

 Key Players:

Antares Pharma, Inc. (US), Bioject Medical Technologies Inc. (US), Endo International plc (US), European Pharma Group (Netherland), PharmaJet (US), Medical International Technology, Inc. (US), Valeritas, Inc. (US), PenJet Corporation (US), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Crossject SA (France), Zogenix, Inc. (US), 3M Company (US) and others are some of the prominent players at the forefront of competition in the global Needle-Free Diabetes Care market and are profiled in MRFR Analysis.

Needle-Free Diabetes Care Market - Overview

Diabetes is a metabolic disorder caused due to insulin deficiency. The administration of the medication through a modern technique known as needle-free diabetic care for the patient. According to the International Diabetes Federation, about 420 million adult population was suffering from diabetes in 2022, which is increasing at the rate of 8.4% per year and is expected to reach 625 million by 2040. Increasing diabetic population across the globe is the main reason for the development of the global needle-free diabetic care market.  Moreover, increasing obese population, increasing healthcare expenditure, and strong encouragement from the government have also contributed to the growth of the market. According to research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.

On account of lack of effective treatment for this disorder, many manufacturers are continuously trying to develop new drugs and more convenient drug delivery devices. Moreover, increasing healthcare expenditure, increasing demand for the better and convenient devices, and development in healthcare infrastructure have contributed to the growth of the market. On the other hand, factors such as, lack of awareness among people and higher cost are hampering the growth of the market.

The global Needle-Free Diabetic Care Market is expected to grow at a CAGR of 7.5% during the forecast period 2022-2027

Needle-Free Diabetes Care Market – Regional Analysis

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.

America dominates the global needle-free diabetes care market owing to large diabetic population. Apart from this, increasing number of obese people, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. According to American Diabetic Association, 29 million Americans were suffering from diabetes in 2022, which is 9.3% of total American population. Obese patients are more prone to diabetes; increasing number of obese population in America is the major driving factor in the growth of the market.

 

Europe is the second largest market, which is followed by Asia Pacific. Increasing awareness among the people and government support for the research and development have encouraged the growth of the market in Europe.

Asia Pacific is the fastest growing region in the global market due to the presence of large diabetic population. China and India contribute a major share in the Asia Pacific needle-free diabetes care market due to the presence of huge diabetic population. Owing to a large diabetic population, Asia Pacific is the fastest growing market in the globe, and according to WHO, more than 60 % of diabetic people in the world are living in Asia Pacific region. Therefore, increasing diabetic and obese population across Asia Pacific driving the growth of the market. Due to rapidly developing economies and increasing healthcare expenditure, boosted the growth of the market. India and China are the major contributors in the Asia Pacific region. According to WHO, about 90 million and 62 million diabetic population is currently present in India and China respectively. By 2030, both of the countries together will have about half a billion diabetic population. The Middle East and Africa contribute least in the global needle-free diabetes care market.

Needle-Free Diabetes Care Market – Company Analysis:

The global Needle Free Blood Sugar Testing is highly fragmented due to the presence of a number multinational and local players. The prominent players in the market adopt various strategies such as new product launch, product innovation, and investment in research and development for the advancement of needle-free devices. Some companies have adopted developmental strategies like merger and acquisition to sustain in the competitive market environment.

For instance, in 2007, INJEX Pharma AG announced FDA clearance to market and sold their needle free injection products in the America. Twin-Jector EZ II and ZOMA-Jet are the most common needle-free injector developed by Antares Pharma Inc.,. Also, the company has got approval for Vision, which is a reusable needle-free injectors, and disposable multi-use pen injectors.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Optical Biometry Devices Market Professional Survey about Therapeutics and Pipeline Review 2022

 Market Scope

Market Research Future (MRFR) assessed the global optical biometry devices market 2021 for the analysis period till 2027. According to MRFR analysis data, the optical biometry device market is expected to surge at 5.6 CAGR over the review period. By 2027, the optical biometry device market is likely to value USD 275.0 Mn.

Market Drivers and Restrains

Ophthalmic biometry, also called as optical biometry, is the current standard used in the calculation of intraocular lens (IOL) power in clinical practice and measure the anatomical characteristics of human eye. Optical biometry with partial coherence interferometry (PCI) offers highly accurate and reliable results. It is not only easy to perform but is non-invasive and is comfortable to patients. The expansion of aging group, increase in awareness about optical biometry and its advantage over ultrasound can benefit market in the years to come. The surge in cases of refractive and cataract and surgeries is also expected to promote the market expansion in the years to come. On the contrary, lack of expertise and surge in cost of optical biometry devices are causes that can hinder the upsurge of optical biometry device market in forecast tenure. The introduction of next-generation optical biometry devices that can offer undetected poor fixations with optical ultrasound biometry devices can benefit the market in the near future. In addition, these the increasing awareness about devices that are highly efficient and eliminate manual errors that are observed in case of traditional biometry devices can prompt the market growth.

The impact of COVID 19 on the global supply of biometric devices market is significant. The optical biometry market dynamics is largely depend on the globally stabilization and the full capacity functioning of the manufacturing units of companies. However, the increase in demand for contact-based biometric systems can prompt the market rise in the years to come.

Optical Biometry Devices Market Key Players

Leica Microsystems GmbH, Carl Zeiss AG, Haag-Streit AG, NIDEK CO., LTD., Bausch & Lomb Incorporated, Topcon Corporation, Welch Allyn, Inc., Tomey Corporation, Heine Optotechnik GmbH & Co. KG, AMETEK, Inc., Optovue, Incorporated, and CENTERVUE S.p.A. are some major companies in the global optical biometry devices market that are profiled by MRFR.

Segmentation Assessment of Optical Biometry Devices Market

The segment study of the global Optical Biometry Devices Market is based on end user and product.

The product-based segments of the optical biometry device market are partial coherence interferometry (PCI)-based biometers, swept-source optical coherence tomography (SSOCT)-based biometers, and optical low coherence reflectometry (OLCR)-based biometers. The segment of swept-source optical coherence tomography (SSOCT) can hold the largest market share by 2027. Features, such as; fast data acquisition, multiple measurements in a single process, and high capability to overcome superior wavelength and ocular opacities of SSOCT can contribute to the expansion of the market. The segment of partial coherence interferometry-based biometers (PCLI) is expected to register rapid rise in the market. PCIL offers advantages of reproducibility of axial length (AL) that provide greater reliability in results.

The end user-based segments of the optical biometry market are ophthalmic clinics, and hospitals among others. The gradual increase in number of private and government hospitals with high adoption rate of optical biometry devices can benefit the market in the review period. The rise in count of ophthalmic clinics to promote market upsurge.

Regional Study of Optical Biometry Devices Market

The optical biometry devices market in the Americas is expected to earn substantial turnover in the years to come. A large portion of the revenue generated is by key marketers in the region. The growing cases of cataract and refractive surgeries and well-established healthcare infrastructure can contribute to the upsurge of the market in the near future. In Europe, the optical biometry devices market can rise at high pace due to rise in the number of cataract procedures in the region, along with the growth inducers responsible for the Americas market. In Asia Pacific, the optical biometry devices market profit can rise owing to spreading awareness about optical biometry and hike in healthcare spending in Australia, India, and Japan. In Middle East & Africa, the optical biometry devices market in the region can rise at modest pace by 2025. The expansion of healthcare sector in MEA and investment by Gulf Cooperation Council (GCC) countries, such as; Kuwait, Saudi Arabia, the Bahrain, United Arab Emirates, Qatar, and Oman can promote the market in the years to come.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America